Peripheral Registry of Endovascular Clinical Outcomes (PRIME) "Research Registry"

November 22, 2017

  • Clinical Trial Information

    Trial Contact: DuPont, Ashley

    Trial Phone: 321.841.1505

  • IRB No: 16.109.09

    Protocol Abbrev: PRIME CLI

    Principal Investigator: Farhan Javed Khawaja, MD

    Age Group: Adult

  • Objective

    The primary objective of PRIME is to systematically document endovascular revascularization approaches and patient outcomes with advanced PVD and CLI both in-hospital and at 1 month, 3 months, 6 months, and annually for 3 years following treatment.

  • Key Eligibility

    Peripheral Arterial Disease